5414x (100% SIMPLE)

: £12.9 million (+27.4%), supported by synthetic biology.

: Continued advancement in national programs like NIHR Bioresource. Strategic and Operational Developments : £12

: A refined commercial strategy identified high-priority opportunities in applied and research markets worth an estimated $13 to $14 billion . : £12.9 million (+27.4%)

"5414X" is the RNS (Regulatory News Service) identifier for the released by Oxford Nanopore Technologies plc . : £12

: Introduced next-generation automated flow cell lines and strengthened quality assurance to ISO 13485 standards.